ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04970	Salivary secretion	5/76	93/8144	0.0017	0.1079	0.09948	AMY1A/AMY1B/AMY1C/CD38/PRH2	5
KEGG	hsa04062	Chemokine signaling pathway	7/76	192/8144	0.002009	0.1079	0.09948	HCK/PIK3R5/NFKB1/CCL20/CCL5/LYN/CXCL8	7
KEGG	hsa04972	Pancreatic secretion	5/76	102/8144	0.002553	0.1079	0.09948	AMY1A/AMY1B/AMY1C/CD38/CELA2A	5
KEGG	hsa04064	NF-kappa B signaling pathway	5/76	104/8144	0.002779	0.1079	0.09948	TNFAIP3/NFKB1/LYN/CXCL8/BCL2A1	5
KEGG	hsa04668	TNF signaling pathway	5/76	112/8144	0.003827	0.1079	0.09948	TNFAIP3/NFKB1/CCL20/CCL5/IL15	5
KEGG	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4/76	70/8144	0.004032	0.1079	0.09948	NFKB1/CCL5/LYN/CXCL8	4
KEGG	hsa00500	Starch and sucrose metabolism	3/76	36/8144	0.00447	0.1079	0.09948	AMY1A/AMY1B/AMY1C	3
KEGG	hsa04973	Carbohydrate digestion and absorption	3/76	47/8144	0.009435	0.1716	0.1582	AMY1A/AMY1B/AMY1C	3
KEGG	hsa05323	Rheumatoid arthritis	4/76	93/8144	0.01094	0.1716	0.1582	CCL20/CCL5/IL15/CXCL8	4
KEGG	hsa05169	Epstein-Barr virus infection	6/76	202/8144	0.0112	0.1716	0.1582	PSMC2/CD44/TNFAIP3/NFKB1/ENTPD1/LYN	6
KEGG	hsa04657	IL-17 signaling pathway	4/76	94/8144	0.01134	0.1716	0.1582	TNFAIP3/NFKB1/CCL20/CXCL8	4
KEGG	hsa05150	Staphylococcus aureus infection	4/76	96/8144	0.01218	0.1716	0.1582	FCGR2C/CFB/C1QC/KRT24	4
KEGG	hsa05142	Chagas disease	4/76	102/8144	0.01495	0.1926	0.1775	NFKB1/CCL5/CXCL8/C1QC	4
KEGG	hsa04625	C-type lectin receptor signaling pathway	4/76	104/8144	0.01595	0.1926	0.1775	NFKB1/CLEC7A/CLEC6A/CLEC4E	4
KEGG	hsa04060	Cytokine-cytokine receptor interaction	7/76	295/8144	0.01974	0.2224	0.205	CCL20/CSF2RB/CCL5/IL15/CXCL8/TNFSF18/INHBE	7
KEGG	hsa05152	Tuberculosis	5/76	180/8144	0.0261	0.2757	0.2542	FCGR2C/NFKB1/IRAK2/CLEC7A/CLEC4E	5
KEGG	hsa04611	Platelet activation	4/76	124/8144	0.02834	0.2817	0.2597	PIK3R5/MYLK4/GNA13/LYN	4
KEGG	hsa05133	Pertussis	3/76	76/8144	0.03378	0.3069	0.2829	NFKB1/CXCL8/C1QC	3
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	5/76	194/8144	0.03451	0.3069	0.2829	HCK/PIK3R5/NFKB1/LYN/CXCL8	5
KEGG	hsa04610	Complement and coagulation cascades	3/76	85/8144	0.04475	0.3781	0.3485	CFB/A2M/C1QC	3
KEGG	hsa05417	Lipid and atherosclerosis	5/76	215/8144	0.04997	0.3999	0.3686	NFKB1/SOD2/CCL5/LYN/CXCL8	5
KEGG	hsa04921	Oxytocin signaling pathway	4/76	154/8144	0.05539	0.3999	0.3686	PIK3R5/CAMK1G/MYLK4/CD38	4
KEGG	hsa04932	Non-alcoholic fatty liver disease	4/76	155/8144	0.05647	0.3999	0.3686	NFKB1/UQCR10/NDUFB8/CXCL8	4
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	5/76	223/8144	0.05679	0.3999	0.3686	NFKB1/SOD2/UQCR10/NDUFB8/PTPN1	5
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	3/76	97/8144	0.06177	0.4176	0.3849	HCK/ASAP1/LYN	3
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	3/76	100/8144	0.06644	0.4319	0.3981	CCL20/CCL5/CXCL8	3
KEGG	hsa05146	Amoebiasis	3/76	102/8144	0.06964	0.4359	0.4018	NFKB1/CXCL8/SERPINB10	3
KEGG	hsa04620	Toll-like receptor signaling pathway	3/76	104/8144	0.07291	0.44	0.4056	NFKB1/CCL5/CXCL8	3
KEGG	hsa05131	Shigellosis	5/76	247/8144	0.08032	0.4681	0.4315	CD44/NFKB1/TNIP1/CCL5/CXCL8	5
KEGG	hsa04621	NOD-like receptor signaling pathway	4/76	184/8144	0.0926	0.5217	0.4809	TNFAIP3/NFKB1/CCL5/CXCL8	4
KEGG	hsa05134	Legionellosis	2/76	57/8144	0.09882	0.5387	0.4966	NFKB1/CXCL8	2
KEGG	hsa05202	Transcriptional misregulation in cancer	4/76	193/8144	0.1056	0.5393	0.4971	ZBTB17/NFKB1/CXCL8/BCL2A1	4
KEGG	hsa04730	Long-term depression	2/76	60/8144	0.1077	0.5393	0.4971	GNA13/LYN	2
KEGG	hsa05020	Prion disease	5/76	273/8144	0.1109	0.5393	0.4971	PSMC2/UQCR10/CCL5/NDUFB8/C1QC	5
KEGG	hsa05130	Pathogenic Escherichia coli infection	4/76	197/8144	0.1117	0.5393	0.4971	NFKB1/GNA13/NCK1/CXCL8	4
KEGG	hsa04623	Cytosolic DNA-sensing pathway	2/76	63/8144	0.1168	0.5413	0.499	NFKB1/CCL5	2
KEGG	hsa05221	Acute myeloid leukemia	2/76	67/8144	0.1292	0.5413	0.499	NFKB1/BCL2A1	2
KEGG	hsa04210	Apoptosis	3/76	136/8144	0.1336	0.5413	0.499	NFKB1/CSF2RB/BCL2A1	3
KEGG	hsa04920	Adipocytokine signaling pathway	2/76	69/8144	0.1355	0.5413	0.499	NFKB1/ACSL1	2
KEGG	hsa04622	RIG-I-like receptor signaling pathway	2/76	70/8144	0.1386	0.5413	0.499	NFKB1/CXCL8	2
KEGG	hsa04917	Prolactin signaling pathway	2/76	70/8144	0.1386	0.5413	0.499	NFKB1/ELF5	2
KEGG	hsa04371	Apelin signaling pathway	3/76	139/8144	0.14	0.5413	0.499	PIK3R5/MYLK4/GNA13	3
KEGG	hsa04936	Alcoholic liver disease	3/76	142/8144	0.1466	0.5413	0.499	NFKB1/CXCL8/C1QC	3
KEGG	hsa03320	PPAR signaling pathway	2/76	75/8144	0.1548	0.5413	0.499	FABP4/ACSL1	2
KEGG	hsa00061	Fatty acid biosynthesis	1/76	18/8144	0.1554	0.5413	0.499	ACSL1	1
KEGG	hsa05016	Huntington disease	5/76	306/8144	0.1567	0.5413	0.499	PSMC2/SOD2/UQCR10/NDUFB8/SLC1A2	5
KEGG	hsa05163	Human cytomegalovirus infection	4/76	225/8144	0.1581	0.5413	0.499	NFKB1/GNA13/CCL5/CXCL8	4
KEGG	hsa04072	Phospholipase D signaling pathway	3/76	148/8144	0.1599	0.5413	0.499	PIK3R5/GNA13/CXCL8	3
KEGG	hsa05140	Leishmaniasis	2/76	77/8144	0.1613	0.5413	0.499	FCGR2C/NFKB1	2
KEGG	hsa05206	MicroRNAs in cancer	5/76	310/8144	0.1627	0.5413	0.499	CD44/NFKB1/MIR10A/MIR135A2/MIR23A	5
KEGG	hsa00531	Glycosaminoglycan degradation	1/76	19/8144	0.1633	0.5413	0.499	HYAL4	1
KEGG	hsa05171	Coronavirus disease - COVID-19	4/76	232/8144	0.1706	0.5498	0.5068	CFB/NFKB1/CXCL8/C1QC	4
KEGG	hsa04146	Peroxisome	2/76	82/8144	0.1779	0.5498	0.5068	SOD2/ACSL1	2
KEGG	hsa04662	B cell receptor signaling pathway	2/76	82/8144	0.1779	0.5498	0.5068	NFKB1/LYN	2
KEGG	hsa00770	Pantothenate and CoA biosynthesis	1/76	21/8144	0.1789	0.5498	0.5068	VNN1	1
KEGG	hsa01232	Nucleotide metabolism	2/76	85/8144	0.188	0.5674	0.523	AMPD3/ENTPD1	2
KEGG	hsa04211	Longevity regulating pathway	2/76	89/8144	0.2016	0.5752	0.5302	NFKB1/SOD2	2
KEGG	hsa04976	Bile secretion	2/76	89/8144	0.2016	0.5752	0.5302	AQP9/SULT2A1	2
KEGG	hsa04977	Vitamin digestion and absorption	1/76	24/8144	0.2018	0.5752	0.5302	CUBN	1
KEGG	hsa04022	cGMP-PKG signaling pathway	3/76	167/8144	0.2042	0.5752	0.5302	PIK3R5/MYLK4/GNA13	3
KEGG	hsa05222	Small cell lung cancer	2/76	92/8144	0.2118	0.5831	0.5375	ZBTB17/NFKB1	2
KEGG	hsa05164	Influenza A	3/76	171/8144	0.2139	0.5831	0.5375	NFKB1/CCL5/CXCL8	3
KEGG	hsa04640	Hematopoietic cell lineage	2/76	99/8144	0.2359	0.6224	0.5738	CD44/CD38	2
KEGG	hsa04744	Phototransduction	1/76	29/8144	0.2384	0.6224	0.5738	GNAT2	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	2/76	100/8144	0.2394	0.6224	0.5738	NFKB1/CXCL8	2
KEGG	hsa01523	Antifolate resistance	1/76	30/8144	0.2456	0.6288	0.5796	NFKB1	1
KEGG	hsa04974	Protein digestion and absorption	2/76	103/8144	0.2498	0.6294	0.5802	SLC7A8/CELA2A	2
KEGG	hsa04660	T cell receptor signaling pathway	2/76	104/8144	0.2533	0.6294	0.5802	NFKB1/NCK1	2
KEGG	hsa04613	Neutrophil extracellular trap formation	3/76	190/8144	0.2611	0.6359	0.5862	NFKB1/AQP9/CLEC7A	3
KEGG	hsa04130	SNARE interactions in vesicular transport	1/76	33/8144	0.2666	0.6359	0.5862	STX11	1
KEGG	hsa04931	Insulin resistance	2/76	108/8144	0.2671	0.6359	0.5862	NFKB1/PTPN1	2
KEGG	hsa05145	Toxoplasmosis	2/76	112/8144	0.281	0.6596	0.6081	PIK3R5/NFKB1	2
KEGG	hsa00760	Nicotinate and nicotinamide metabolism	1/76	36/8144	0.287	0.663	0.6112	CD38	1
KEGG	hsa05143	African trypanosomiasis	1/76	37/8144	0.2937	0.663	0.6112	IDO2	1
KEGG	hsa05415	Diabetic cardiomyopathy	3/76	203/8144	0.2942	0.663	0.6112	NFKB1/UQCR10/NDUFB8	3
KEGG	hsa04071	Sphingolipid signaling pathway	2/76	119/8144	0.3053	0.67	0.6176	NFKB1/GNA13	2
KEGG	hsa04722	Neurotrophin signaling pathway	2/76	119/8144	0.3053	0.67	0.6176	NFKB1/IRAK2	2
KEGG	hsa04216	Ferroptosis	1/76	41/8144	0.3198	0.6817	0.6284	ACSL1	1
KEGG	hsa05219	Bladder cancer	1/76	41/8144	0.3198	0.6817	0.6284	CXCL8	1
KEGG	hsa00380	Tryptophan metabolism	1/76	42/8144	0.3262	0.6817	0.6284	IDO2	1
KEGG	hsa00071	Fatty acid degradation	1/76	43/8144	0.3325	0.6817	0.6284	ACSL1	1
KEGG	hsa00230	Purine metabolism	2/76	128/8144	0.3362	0.6817	0.6284	AMPD3/ENTPD1	2
KEGG	hsa04380	Osteoclast differentiation	2/76	128/8144	0.3362	0.6817	0.6284	FCGR2C/NFKB1	2
KEGG	hsa03050	Proteasome	1/76	46/8144	0.3511	0.6817	0.6284	PSMC2	1
KEGG	hsa00190	Oxidative phosphorylation	2/76	134/8144	0.3567	0.6817	0.6284	UQCR10/NDUFB8	2
KEGG	hsa04270	Vascular smooth muscle contraction	2/76	134/8144	0.3567	0.6817	0.6284	MYLK4/GNA13	2
KEGG	hsa05135	Yersinia infection	2/76	137/8144	0.3668	0.6817	0.6284	NFKB1/CXCL8	2
KEGG	hsa04714	Thermogenesis	3/76	232/8144	0.3687	0.6817	0.6284	UQCR10/NDUFB8/ACSL1	3
KEGG	hsa04672	Intestinal immune network for IgA production	1/76	49/8144	0.3692	0.6817	0.6284	IL15	1
KEGG	hsa05030	Cocaine addiction	1/76	49/8144	0.3692	0.6817	0.6284	NFKB1	1
KEGG	hsa05162	Measles	2/76	139/8144	0.3735	0.6817	0.6284	TNFAIP3/NFKB1	2
KEGG	hsa05418	Fluid shear stress and atherosclerosis	2/76	139/8144	0.3735	0.6817	0.6284	NFKB1/MIR10A	2
KEGG	hsa05144	Malaria	1/76	50/8144	0.3751	0.6817	0.6284	CXCL8	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	2/76	143/8144	0.3869	0.6922	0.6381	INHBE/KAT6A	2
KEGG	hsa04020	Calcium signaling pathway	3/76	240/8144	0.3891	0.6922	0.6381	CAMK1G/MYLK4/CD38	3
KEGG	hsa04923	Regulation of lipolysis in adipocytes	1/76	56/8144	0.4095	0.7085	0.6532	FABP4	1
KEGG	hsa01212	Fatty acid metabolism	1/76	57/8144	0.4151	0.7085	0.6532	ACSL1	1
KEGG	hsa04145	Phagosome	2/76	152/8144	0.4165	0.7085	0.6532	FCGR2C/CLEC7A	2
KEGG	hsa04144	Endocytosis	3/76	251/8144	0.417	0.7085	0.6532	ASAP1/EHD1/RAB4A	3
KEGG	hsa00240	Pyrimidine metabolism	1/76	58/8144	0.4206	0.7085	0.6532	ENTPD1	1
KEGG	hsa04218	Cellular senescence	2/76	156/8144	0.4295	0.7085	0.6532	NFKB1/CXCL8	2
KEGG	hsa04978	Mineral absorption	1/76	60/8144	0.4314	0.7085	0.6532	ATOX1	1
KEGG	hsa00561	Glycerolipid metabolism	1/76	61/8144	0.4368	0.7085	0.6532	GPAT2	1
KEGG	hsa04213	Longevity regulating pathway - multiple species	1/76	62/8144	0.4421	0.7085	0.6532	SOD2	1
KEGG	hsa05014	Amyotrophic lateral sclerosis	4/76	364/8144	0.4433	0.7085	0.6532	PSMC2/UQCR10/NDUFB8/SLC1A2	4
KEGG	hsa04630	JAK-STAT signaling pathway	2/76	162/8144	0.4486	0.7085	0.6532	CSF2RB/IL15	2
KEGG	hsa05161	Hepatitis B	2/76	162/8144	0.4486	0.7085	0.6532	NFKB1/CXCL8	2
KEGG	hsa05012	Parkinson disease	3/76	266/8144	0.4543	0.7096	0.6541	PSMC2/UQCR10/NDUFB8	3
KEGG	hsa05321	Inflammatory bowel disease	1/76	65/8144	0.4577	0.7096	0.6541	NFKB1	1
KEGG	hsa00830	Retinol metabolism	1/76	68/8144	0.4728	0.7199	0.6636	ALDH1A1	1
KEGG	hsa04664	Fc epsilon RI signaling pathway	1/76	68/8144	0.4728	0.7199	0.6636	LYN	1
KEGG	hsa05204	Chemical carcinogenesis - DNA adducts	1/76	69/8144	0.4778	0.7209	0.6646	SULT2A1	1
KEGG	hsa05010	Alzheimer disease	4/76	384/8144	0.4848	0.7228	0.6663	PSMC2/NFKB1/UQCR10/NDUFB8	4
KEGG	hsa04520	Adherens junction	1/76	71/8144	0.4876	0.7228	0.6663	PTPN1	1
KEGG	hsa05214	Glioma	1/76	75/8144	0.5066	0.7322	0.675	CAMK1G	1
KEGG	hsa04971	Gastric acid secretion	1/76	76/8144	0.5112	0.7322	0.675	MYLK4	1
KEGG	hsa05212	Pancreatic cancer	1/76	76/8144	0.5112	0.7322	0.675	NFKB1	1
KEGG	hsa05220	Chronic myeloid leukemia	1/76	76/8144	0.5112	0.7322	0.675	NFKB1	1
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	1/76	78/8144	0.5204	0.7329	0.6756	SULT2A1	1
KEGG	hsa04721	Synaptic vesicle cycle	1/76	78/8144	0.5204	0.7329	0.6756	SLC1A2	1
KEGG	hsa04012	ErbB signaling pathway	1/76	85/8144	0.5512	0.7608	0.7013	NCK1	1
KEGG	hsa04742	Taste transduction	1/76	86/8144	0.5554	0.7608	0.7013	TAS2R4	1
KEGG	hsa04260	Cardiac muscle contraction	1/76	87/8144	0.5596	0.7608	0.7013	UQCR10	1
KEGG	hsa04512	ECM-receptor interaction	1/76	88/8144	0.5637	0.7608	0.7013	CD44	1
KEGG	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/76	89/8144	0.5679	0.7608	0.7013	NFKB1	1
KEGG	hsa05203	Viral carcinogenesis	2/76	204/8144	0.5717	0.7608	0.7013	NFKB1/LYN	2
KEGG	hsa05205	Proteoglycans in cancer	2/76	205/8144	0.5744	0.7608	0.7013	CD44/MIR10A	2
KEGG	hsa04658	Th1 and Th2 cell differentiation	1/76	92/8144	0.58	0.7608	0.7013	NFKB1	1
KEGG	hsa04350	TGF-beta signaling pathway	1/76	94/8144	0.5879	0.7608	0.7013	INHBE	1
KEGG	hsa04740	Olfactory transduction	4/76	440/8144	0.5938	0.7608	0.7013	OR52N5/OR2AK2/OR5H1/OR8H1	4
KEGG	hsa05215	Prostate cancer	1/76	97/8144	0.5994	0.7608	0.7013	NFKB1	1
KEGG	hsa00564	Glycerophospholipid metabolism	1/76	98/8144	0.6032	0.7608	0.7013	GPAT2	1
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	1/76	98/8144	0.6032	0.7608	0.7013	ASIC5	1
KEGG	hsa04925	Aldosterone synthesis and secretion	1/76	98/8144	0.6032	0.7608	0.7013	CAMK1G	1
KEGG	hsa04810	Regulation of actin cytoskeleton	2/76	218/8144	0.6082	0.7614	0.7019	MYLK4/GNA13	2
KEGG	hsa04024	cAMP signaling pathway	2/76	221/8144	0.6157	0.7626	0.703	NFKB1/FFAR2	2
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	2/76	222/8144	0.6182	0.7626	0.703	NFKB1/IL15	2
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	1/76	106/8144	0.6322	0.7743	0.7137	GNA13	1
KEGG	hsa04659	Th17 cell differentiation	1/76	108/8144	0.6392	0.7757	0.715	NFKB1	1
KEGG	hsa04066	HIF-1 signaling pathway	1/76	109/8144	0.6426	0.7757	0.715	NFKB1	1
KEGG	hsa04725	Cholinergic synapse	1/76	113/8144	0.6559	0.779	0.7181	PIK3R5	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	4/76	476/8144	0.6565	0.779	0.7181	PSMC2/NFKB1/UQCR10/NDUFB8	4
KEGG	hsa04724	Glutamatergic synapse	1/76	114/8144	0.6592	0.779	0.7181	SLC1A2	1
KEGG	hsa05132	Salmonella infection	2/76	249/8144	0.6806	0.7988	0.7364	NFKB1/CXCL8	2
KEGG	hsa04110	Cell cycle	1/76	126/8144	0.6959	0.8111	0.7477	ZBTB17	1
KEGG	hsa04926	Relaxin signaling pathway	1/76	129/8144	0.7045	0.814	0.7504	NFKB1	1
KEGG	hsa04068	FoxO signaling pathway	1/76	131/8144	0.7101	0.814	0.7504	SOD2	1
KEGG	hsa04142	Lysosome	1/76	132/8144	0.7128	0.814	0.7504	HYAL4	1
KEGG	hsa05322	Systemic lupus erythematosus	1/76	136/8144	0.7236	0.8157	0.7519	C1QC	1
KEGG	hsa04910	Insulin signaling pathway	1/76	137/8144	0.7262	0.8157	0.7519	PTPN1	1
KEGG	hsa04915	Estrogen signaling pathway	1/76	138/8144	0.7288	0.8157	0.7519	KRT24	1
KEGG	hsa05017	Spinocerebellar ataxia	1/76	143/8144	0.7414	0.8244	0.7599	PSMC2	1
KEGG	hsa03040	Spliceosome	1/76	147/8144	0.7511	0.8266	0.762	SNRPC	1
KEGG	hsa04723	Retrograde endocannabinoid signaling	1/76	148/8144	0.7535	0.8266	0.762	NDUFB8	1
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	1/76	150/8144	0.7582	0.8266	0.762	PIK3R5	1
KEGG	hsa01240	Biosynthesis of cofactors	1/76	153/8144	0.765	0.8287	0.764	IDO2	1
KEGG	hsa05160	Hepatitis C	1/76	157/8144	0.7738	0.8323	0.7672	NFKB1	1
KEGG	hsa04217	Necroptosis	1/76	159/8144	0.7781	0.8323	0.7672	TNFAIP3	1
KEGG	hsa04360	Axon guidance	1/76	182/8144	0.822	0.8737	0.8054	NCK1	1
KEGG	hsa04151	PI3K-Akt signaling pathway	2/76	354/8144	0.8493	0.893	0.8232	PIK3R5/NFKB1	2
KEGG	hsa04510	Focal adhesion	1/76	201/8144	0.8517	0.893	0.8232	MYLK4	1
KEGG	hsa04015	Rap1 signaling pathway	1/76	210/8144	0.864	0.893	0.8232	DOCK4	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	1/76	212/8144	0.8665	0.893	0.8232	NFKB1	1
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	1/76	212/8144	0.8665	0.893	0.8232	NFKB1	1
KEGG	hsa04014	Ras signaling pathway	1/76	232/8144	0.8899	0.9115	0.8403	NFKB1	1
KEGG	hsa04010	MAPK signaling pathway	1/76	294/8144	0.9396	0.9566	0.8819	NFKB1	1
KEGG	hsa05168	Herpes simplex virus 1 infection	2/76	495/8144	0.9503	0.9617	0.8865	NFKB1/CCL5	2
KEGG	hsa05165	Human papillomavirus infection	1/76	331/8144	0.9579	0.9636	0.8883	NFKB1	1
KEGG	hsa04080	Neuroactive ligand-receptor interaction	1/76	362/8144	0.9689	0.9689	0.8932	NPS	1